Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This is a non-randomized, purely observational, feasibility study to detect metabolic changes
in patients with brain malignancy using a novel hyperpolarized [1-13C]pyruvate MRSI.